Back

Activation specific CD11b inhibition mitigates immune checkpoint inhibitor associated cardiac and intestinal toxicity while preserving anti tumor effects

20 June 2026 (10:03 - 10:12)
Organised by: Logo
Congress Presentation Part of: Digging deeper into ICI cardiovascular toxicity Research and New Technology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Istvan Bojti

University Heart Center Freiburg-Bad Krozingen, Freiburg (Germany)

3 More presentations in this session

Presentation thumbnail
Quantitative assessment of infiltrating macrophages could provide clues for predicting the prognosis in the patients with immune checkpoint inhibitor-associated myocarditis
Doctor H. Yamamoto (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Elevated levels of PD-L1 are associated with rs72705424 and increased risk of incident cardiovascular disease in the UK Biobank
Ms A. Sijtema (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Immune checkpoint inhibitors promote endothelial inflammatory responses
Assistant Professor C. Franssen (Edegem, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Digging deeper into ICI cardiovascular toxicity
Video

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 10:03 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources